|
Post by kc on Oct 10, 2017 17:01:33 GMT -5
I am wondering for how long and for how high will the rate go considering current pps? There could be 2 outcomes: 1: we get rate 75-100% until end of the year and buy out at $50 per share or 2: pps climbs to $25 and they do split back to original number of shares Why do you want to split back once you climb to $25? Really sees no reason for that. Stocks trading above $100 is quite common nowadays. I have shares in Intuitive surgical They just split their stock 3 (three) way from $1,085 to $367.00 I liked them better prior to the split.
|
|
|
Post by kc on Oct 10, 2017 16:56:41 GMT -5
Sla, I think Al did say he wouldn't sell for less than $125 pre-split, so that would be $625, but there has been so much water under and over the bridge since that comment was made, it's virtually meaningless today. In fact, I think the bridge was washed away and we've been using a makeshift pontoon bridge for quite a while. Dreaming has always been part of the MannKind cult club. We have dreamed of our riches as we go to work everyday. But perhaps one Day SHORTLY we will wake up to the news of a Buyout? What number would make me happy? Good Question. I don't have one yet! I do know that what my original invested cost was on the Pre-Reverse split shares. So I can back into a number if needed. Being a realist that number for me today would be anything over $15.00 would make the experience a good one but anything over $30.00 would be a double. $45. a triple and $50 a Home run.
Did I mention a Grand slam would anything over $60.00?
One final point is that I would prefer to own this stock for many years and would prefer that we stay independent and be more like Regeneron and having an invested partner.
|
|
|
Post by kc on Oct 10, 2017 13:53:42 GMT -5
In 3 of the last 4 trading says there have been sell offs between the times of 130 and 2 eastern time. Just an observation, as it seems to be happening now. when Europe closes, volume falls off is a trend I type about.
That premarket premarket volume is Europe.
Pfizer, Lilly, sanofi. Europe. hmmm
Strike one from the list.... But add Norvo Nordisk to the list.
Pfizer, Lilly, sanofi.
Europe.
hmmm
|
|
|
Post by kc on Oct 10, 2017 12:10:09 GMT -5
To think that Aegis Capital called me a couple of weeks ago when MNKD was still in the 2's. They told me that MNKD was done its run and it was time to move on. They had several suggestions for stocks that were ready to move up and would happily manage my portfolio for me. I told them I managed my own investments and didn't agree with them on MNKD. It serves as a reminder why I resolved many decades ago to make my own investment decisions and not follow the advice of major brokers and investment bankers. Why do they call them Broker's ? Because they will make you Broker......
Where did I put my Aegis yellow cards........
|
|
|
Post by kc on Oct 10, 2017 11:56:37 GMT -5
Fidelity increased rate paid twice this morning. 54.625% last I checked. But their loan rate dropped to 97% from 99% yesterday.
|
|
|
Post by kc on Oct 10, 2017 11:54:57 GMT -5
Spiro, It's OK to tell them the truth. We had no internet in Siberia. Wow another name from the past..... ashiwi.....
|
|
|
Post by kc on Oct 10, 2017 11:16:31 GMT -5
Bring on a hostile takeover attempt by all means! I guess we don't yet have the short interest numbers as of 9/30; but, in any event, even those will not tell the story, we need to see what is happening in early October, too, and that won't be out for more than two weeks. Very curious. Part of this rally just has to be some short covering. And, no doubt, some new short positions have been born recently, so it makes it difficult to get a fix on what's happening in the short world. Gosh, it would be great to have the numbers day to day. I used to say many years ago that a hostile take over attempt would create a bidding war. My guess is that eventually somebody will come forward with a 10% interest and make the Board put the company up for sale and then the Bidding war occurs. Frankly I'm surprised it has not happened yet. I would love to be invested with my current share level for another five years if we have truly turned the corner.
If Big pharma wakes up and realizes what Afrezza is really all about then our days will be numbered as a big offer will come in and we will part of another big Pharma. Its been a very interesting road.
|
|
|
Post by kc on Oct 10, 2017 11:08:28 GMT -5
When I think of Spiro, I want to go get me some Mallomars..... Maybe if we hit $45.00 per share I could buy several cases of them.
|
|
|
Post by kc on Oct 10, 2017 10:15:35 GMT -5
Good Morning MannKind! Love seeing the upper end of the day range at $6.96 Now that would be fantastic if we actually closed above $7.00.
There is serious blood in the water. Not sure what is going on but it seems that Mike has been like the wizard working behind the curtain and SHORTLY something good will be revealed. I'm still in Kansas which is the land Oz but evidently Mike MannKind and his team have hit the big stage and will move in front of the curtain SHORTLY.
GTLA......
|
|
|
Post by kc on Oct 9, 2017 12:19:31 GMT -5
Metformin is the standard of care. It’s what docs hav been taught to do, it’s what they know. Until they know something else they will continue prescribing Metformin. They prescribe Metformin as you can get it for .25 per pill. Cheap and easy to prescribe for all medical plans. It does not matter that the outcome is not what a person wants. Its the outcome of the insurance community that matters.
|
|
|
Post by kc on Oct 9, 2017 12:15:23 GMT -5
If somebody has been buying or did accumulate 5% they have to announce it very timely. It could happen. Would not surprise me as that should have happened a long time ago.
|
|
|
Post by kc on Oct 8, 2017 15:45:16 GMT -5
Oh my 😇
It it was on stocktwits
ok. I understand. 😉
|
|
|
Post by kc on Oct 8, 2017 7:56:29 GMT -5
|
|
|
Post by kc on Oct 7, 2017 16:50:56 GMT -5
I just watched Friday's Mad Money and I've just have to share my thoughts with you all. His producers finally let a question through about MNKD for the first time in forever and he did not dismiss it off hand like he has in the past. I didn't even see it in his words, tone or body language. Trust me, I've been studying Cramer's show and his investment style since it started and you get to know a persons expressions and phraseology pretty well. The key takeaway here is the backstory not all of you may know. Adam Feurstein is Cramer's go-to guy in biotech. He's got a whole staff of researchers at his disposal too but AF has historically been his guy. AF is an infamous character in Mannkind support circles because of his very obvious negative view on Mannkind and it's prospects since the beginning. To be frank, well, it's rubbed some members of the Mannkind "cult" the wrong way. He's been harassed by some Mannkind followers over the years, further adding to his contempt of the company IMO. Don't hate me for saying this but I have seen what he saw in Mannkind Management all along. They weren't ready to become "Big Pharma" by a long shot. Be honest, all of you have noticed the extreme difference between Al's, Hakan's, Matt's and Mike's approach to the CEO position. I liked Al, Hakan, and especially Matt. He was doing great things for the future of Mannkind. They were just seen as, let's say milk toast by the extra savvy analysts from the investment world. Mike, and Steve Binder the CFO are being accepted more like pedigree Wall Street guys. And now, they have something none of the former leaders of Mannkind ever had, accelerated revenue growth or ARG. Cramer LOVES "ARRGGHH" as he says it. it may take a month or two for him to complete his take on us. To be honest, I'd like to have the recapitalization completed before he opines. Cramer knows that even great science can be lost without the proper management. I hope he brings Mike Castagna on the show for optimal effect. I don't know if AF is behind the acceptance of a MNKD review, but believe me when I say if we can change the minds of AF and Cramer, we could end up the next Regeneron. Those guys know how Wall Street thinks. To this long suffering investor, after the glorious events of this week, Friday's Mad Money was icing on my big old Mannkind cake. Holding 10,000 shares until my retirement in 98 months, GOOD LUCK TO ALL OF YOU Did anybody go back to his podcast and listen to it. I am traveling so I have not done so. I could not find your transcribe anywhere on the mad money recap.
|
|
|
Post by kc on Oct 6, 2017 22:12:46 GMT -5
Visiting the great Northwest and the city of Seattle for business. While taking a tour today the tour bus driver indicated Paul Allen has beginning parkinson's disease. It is well known in Seattle that the Allen institute is trying to work on cures for parkinson's and Alzheimer's. It would not surprise RLS Receptor life sciences is part of the alleninstitute.org/
|
|